Navigation Links
Prostate cancer treatment overused in some older patients
Date:2/27/2012

Treatment is not always warranted for older men with prostate cancer and a short life expectancy, Yale School of Medicine researchers report in the Feb. 27 Archives of Internal Medicine.

"Treatment can do more harm than good in some instances," said senior author on the study Cary Gross, M.D., associate professor of internal medicine at Yale School of Medicine. "Among men who are older and have less aggressive forms of prostate cancer, their cancer is unlikely to progress or cause them harm in their remaining years."

Gross and his team analyzed nine years of Medicare data and found that over the past decade, there has been a trend towards higher use of curative treatment for prostate cancer among men with certain types of tumors and a short life expectancy. The study included 39,270 patients between the ages of 67 and older.

These results suggest that cancer treatment was increasingly aggressive in patients who had the lowest likelihood of seeing clinical benefits, Gross said, noting that while not treating potentially fatal cancer can reflect poor-quality care, aggressively managing disease that is unlikely to progress puts patients at risk for complications and increases costs without medical benefits.

"We found that the percentage of men who received treatment for their prostate cancer treatments increased over time from 61.2% to 67.6% from 1998 through 2007," said Gross, who is a member of Yale Cancer Center. "However, we were surprised to find that the biggest increase was among men with moderate-risk prostate cancer who had the shortest life expectancy. On the other hand, cancer treatment decreased among men with low-risk tumors and longer life expectancy."

Treating patients with shorter life expectancy may add costs or complications without contributing to quality of life, he said. The National Comprehensive Cancer Network practice guidelines in oncology recommend actively monitoring patients as an
'/>"/>

Contact: Karen N. Peart
karen.peart@yale.edu
203-432-1326
Yale University
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Telomere failure, telomerase activation drive prostate cancer progression
2. Nerve-Sparing Prostate Surgery Helps Men Retain Sexual Function
3. New method makes it easier to treat prostate and pancreatic cancer
4. Curry spice component may help slow prostate tumor growth
5. Heart disease may be a risk factor for prostate cancer
6. A new screening method for prostate cancer
7. Investigational urine test can predict high-risk prostate cancer in men who chose watchful waiting
8. Vigorous exercise linked to gene activity in prostate
9. Prostate cancer risk halved for subfertile men
10. Science Shows How Exercise Might Help in Prostate Cancer
11. Study Compares 3 Common Prostate Cancer Treatments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/6/2015)... Medical Products, Inc., a Mississippi Corporation, ... GE Healthcare to become an authorized distributor for GE ... MPI has 31 years in distribution within the U.S. ... this agreement, MPI will have the opportunity to extend ... , MPI has always strived to provide our ...
(Date:3/6/2015)... 06, 2015 The Public Health ... five-year accreditation status to seven more health departments. This ... 1.3 million people can now be assured that their ... the health of their communities. , Public health departments ... health of people and communities. Across the nation, health ...
(Date:3/5/2015)... London, UK (PRWEB) March 06, 2015 ... of them being first–in-class. AstraZeneca tops the list scoring ... field obtained over 25% of all FDA approved drug ... total. First-in-class mechanisms such as anti-PCSK9, anti-PD1 and CDK ... have been approved by the FDA to treat metastatic ...
(Date:3/5/2015)... York, NY (PRWEB) March 05, 2015 Shania ... time in more than a decade. She has hinted that ... want to miss seeing her perform one last time. She ... years and this beloved country sweetheart has millions of loyal fans ... touring throughout her native country, Canada, and on June 30th she ...
(Date:3/5/2015)... A Bakersfield, Calif. state court jury returned ... awarding the plaintiff Coleen M. Perry a total of $5.7 ... TVT-Abbrevo pelvic mesh sling device, manufactured by Ethicon, Inc., a ... a partner at Wagstaff & Cartmell in Kansas ... along with Rich Freese and Tim Goss of Freese ...
Breaking Medicine News(10 mins):Health News:Nearly 113 Million U.S. Residents Now Reaping Benefits of National Public Health Department Accreditation 2Health News:Nearly 113 Million U.S. Residents Now Reaping Benefits of National Public Health Department Accreditation 3Health News:World Pharma Business and Large-Cap Companies Discussed by MP Advisors in In-demand Study Available at MarketPublishers.com 2Health News:World Pharma Business and Large-Cap Companies Discussed by MP Advisors in In-demand Study Available at MarketPublishers.com 3Health News:Shania Twain Tickets: Ticket Down Announces Shania Twain's 2015 “Rock This Country” North American Tour 2Health News:Shania Twain Tickets: Ticket Down Announces Shania Twain's 2015 “Rock This Country” North American Tour 3Health News:Client Wins $5.7 Million in TVT-Abbrevo Verdict against Johnson & Johnson in California State Court 2
... to Simulcast On The N and Nick at Nite Friday, July 11, at ... ... Champion of Fitness, Laila Ali; 12 High School Students Take On the ... Compete For $25,000, NEW YORK, June 18 The N, the network ...
... that made the discovery, Professor Christopher Rowe of the ... presents medical practitioners with the best opportunity to delay ... an experimental stage, this work places Australia at the ... , A 2004 Access Economics report calculated that if ...
... beer and spirits bigger than the standard, study finds , , ... to a bar and assume one drink an hour won,t ... that bartenders pack a lot more booze into common drinks ... and restaurants in Northern California last year and found that ...
... BlueCross,BlueShield of South Carolina Foundation will grant $1.5 ... Carolina,Nurses Foundation, Inc. Distributed over three years, the ... nurses who will then become faculty in,nursing education ... experiencing a serious nursing shortage due to the,retirement ...
... ATSI ), manufacturer and marketer of state-of-the-art ... at the Piper,Jaffray Europe Conference in London, England ... CEO of ATS Medical will present at 9:00 ... Attendance at the conference is by invitation only. ...
... 18 Georgetown University, Gentag,Inc., and Science ... forces to develop a non-invasive method for ... combine their,respective intellectual property (IP) and expertise ... using disposable skin patches with wireless sensors ...
Cached Medicine News:Health News:The N Shapes Up This Summer With the New One-Hour Teen Reality Series, The N's Student Body 2Health News:The N Shapes Up This Summer With the New One-Hour Teen Reality Series, The N's Student Body 3Health News:The N Shapes Up This Summer With the New One-Hour Teen Reality Series, The N's Student Body 4Health News:Advance towards early Alzheimer's diagnosis 2Health News:Bar Drinks Pack More Punch Than Thought 2Health News:BlueCross' $1.5 Million Nursing Scholarships to Ease Nursing Faculty Shortage 2Health News:BlueCross' $1.5 Million Nursing Scholarships to Ease Nursing Faculty Shortage 3Health News:ATS Medical to Participate at the Piper Jaffray Europe Conference 2Health News:No More Needles? Georgetown University Teams with Gentag and SAIC to Develop New Glucose Sensor Technology with Wireless Connection to Cell Phones 2Health News:No More Needles? Georgetown University Teams with Gentag and SAIC to Develop New Glucose Sensor Technology with Wireless Connection to Cell Phones 3
(Date:3/6/2015)... 2015  Isis Pharmaceuticals, Inc. (NASDAQ: ISIS ... million milestone payment from Biogen Idec related to advancing ... in infants with spinal muscular atrophy (SMA).  ... Rx, is a randomized, double-blind, sham-procedure controlled thirteen ... The study will evaluate the efficacy and safety of ...
(Date:3/5/2015)... , March 5, 2015 BioLineRx ... clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and ... has commenced an underwritten public offering of American ... its Ordinary Shares. All of the ADSs in ... JMP Securities is acting as ...
(Date:3/5/2015)... , March 5, 2015 Vermillion, ... solutions company focused on gynecologic disease, announced today ... results before the market open on Wednesday, March ... and webcast at 8:30am Eastern. Conference Call & ... at 8:30am Eastern/5:30am Pacific Domestic: , 800-753-9057International: , ...
Breaking Medicine Technology:Isis Pharmaceuticals Earns $9M for Advancing ISIS-SMN Rx in Infants With Spinal Muscular Atrophy 2Isis Pharmaceuticals Earns $9M for Advancing ISIS-SMN Rx in Infants With Spinal Muscular Atrophy 3Isis Pharmaceuticals Earns $9M for Advancing ISIS-SMN Rx in Infants With Spinal Muscular Atrophy 4Isis Pharmaceuticals Earns $9M for Advancing ISIS-SMN Rx in Infants With Spinal Muscular Atrophy 5BioLineRx Announces Underwritten Public Offering of its American Depositary Shares 2BioLineRx Announces Underwritten Public Offering of its American Depositary Shares 3Vermillion to Report Fourth Quarter and Year-End 2014 Financial Results and Host an Investor Conference Call on March 25 2
... Siemens Medical Solutions, Solidifies Its ... HOFFMAN ESTATES, Ill., Sept. 10 The ... words," but that value is undoubtedly higher,in ... years of,work. Siemens Medical Solutions, Molecular Imaging ...
... log10 (>99%) Mean HCV RNA Decrease with No ... Serious Adverse Events - ... -, PRINCETON, N.J., Sept. 10 Pharmasset, Inc.,(Nasdaq: VRUS ) reports ... 40 patients chronically,infected with hepatitis C virus (HCV) who have failed prior interferon,therapy. ...
Cached Medicine Technology:Siemens Preclinical Imaging System Helps The Methodist Hospital in Houston Further Its Research Mission 2Siemens Preclinical Imaging System Helps The Methodist Hospital in Houston Further Its Research Mission 3Siemens Preclinical Imaging System Helps The Methodist Hospital in Houston Further Its Research Mission 4Siemens Preclinical Imaging System Helps The Methodist Hospital in Houston Further Its Research Mission 5R7128 Demonstrates Safety and Potent Antiviral Activity in HCV-Infected Patients 2R7128 Demonstrates Safety and Potent Antiviral Activity in HCV-Infected Patients 3R7128 Demonstrates Safety and Potent Antiviral Activity in HCV-Infected Patients 4R7128 Demonstrates Safety and Potent Antiviral Activity in HCV-Infected Patients 5R7128 Demonstrates Safety and Potent Antiviral Activity in HCV-Infected Patients 6
The fabric is antistatic and non-linting and is both oil and water repellent.These superior blankets are an environmental friendly alternative to disposable blankets....
The lower body blanket is utilized during surgical procedures covering the head, neck, arms and upper torso of your patient....
The Thermal pads were designed to simulate water immersion, the most effective method of transferring energy non-invasively....
This blanket is ideal for warming the large child or small adult during upper body surgery....
Medicine Products: